These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 13176166)

  • 1. [Pyrogenic substances in injectable solutions].
    CHARONNAT ; LECHAT
    Minerva Farm; 1954 Mar; 3(3):55-61. PubMed ID: 13176166
    [No Abstract]   [Full Text] [Related]  

  • 2. [Removal of pyrogenic substances from injection solutions by filtration].
    WILKE H; VOSS HE
    Arzneimittelforschung; 1954 Jan; 4(1):8-14. PubMed ID: 13140046
    [No Abstract]   [Full Text] [Related]  

  • 3. [Research on pyrogenic substances in injectable aqueous solutions. V. Origin of pyrogenic properties; distilled water and bacterial cultures].
    DORCHE J; CARRAZ M; CASTAING M
    Ann Pharm Fr; 1951; 9(9-10):574-88. PubMed ID: 14915278
    [No Abstract]   [Full Text] [Related]  

  • 4. [Research on pyrogenic substances in injectable aqueous solutions. VI. Attenuation of the pyrogenic properties during aging of sterile bacterial preparations].
    DORCHE J; CASTAING M
    Ann Pharm Fr; 1951; 9(9-10):583-5. PubMed ID: 14915279
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pyrogenicity and microbiota of injectable solutions].
    Lena P
    Boll Chim Farm; 1980 Jan; 119(1):1-22. PubMed ID: 7447998
    [No Abstract]   [Full Text] [Related]  

  • 6. Fever and circulating cytokines induced by double-stranded RNA in guinea pigs: dependence on the route of administration and effects of repeated injections.
    Voss T; Rummel C; Gerstberger R; Hübschle T; Roth J
    Acta Physiol (Oxf); 2006 Jul; 187(3):379-89. PubMed ID: 16776663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Origin, chemistry and properties of pyrogenic substances].
    ULLMANN E
    Arzneimittelforschung; 1953 Feb; 3(2):90-3. PubMed ID: 13066347
    [No Abstract]   [Full Text] [Related]  

  • 8. [System enabling identification of injectable solutions on the basis of spectral characteristics. I. Spectral characteristics of injectable solutions in decimal dilution].
    Krepinský J
    Cesk Farm; 1969 Jan; 18(1):2-8. PubMed ID: 5769659
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pyrogenic substances in injectable liquids].
    TOFFOLI C
    Farmaco Sci Tec; 1947; 2(3):240-6. PubMed ID: 20260533
    [No Abstract]   [Full Text] [Related]  

  • 10. [ON THE FILTRATION OF INJECTABLE SOLUTIONS IN PHARMACEUTICAL PRACTICE].
    BRAGINSKAIA EN
    Aptechn Delo; 1963; 12():59-62. PubMed ID: 14072500
    [No Abstract]   [Full Text] [Related]  

  • 11. [Observations on examination for the presence of pyrogenic substances].
    DESPERAK A; KRYSICKA-DOCZKAL H; WOJCIK R
    Pharmazie; 1960 Aug; 15():446-9. PubMed ID: 13722213
    [No Abstract]   [Full Text] [Related]  

  • 12. High sensitivity pyrogen testing in water and dialysis solutions.
    Daneshian M; Wendel A; Hartung T; von Aulock S
    J Immunol Methods; 2008 Jul; 336(1):64-70. PubMed ID: 18474369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [System for the identification of manufactured injectable solutions on the basis of spectral characteristics. II. Classification system].
    Krepinský J
    Cesk Farm; 1969 Mar; 18(2):66-9. PubMed ID: 5779794
    [No Abstract]   [Full Text] [Related]  

  • 14. Pyrogenic cytokines did not mediate a stress interview-induced hyperthermic response in a patient with psychogenic fever: a case report.
    Hiramoto T; Oka T; Yoshihara K; Kubo C
    Psychosom Med; 2009 Nov; 71(9):932-6. PubMed ID: 19875636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Season, fever prevalence and pyrogenic threshold for malaria disease definition in an endemic area of Mali.
    Dicko A; Mantel C; Kouriba B; Sagara I; Thera MA; Doumbia S; Diallo M; Poudiougou B; Diakite M; Doumbo OK
    Trop Med Int Health; 2005 Jun; 10(6):550-6. PubMed ID: 15941418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Importance of pyrogenic substances in clinic medicine and practice].
    RUDAT KD
    Dtsch Gesundheitsw; 1954 Sep; 9(39):1149-53. PubMed ID: 13220023
    [No Abstract]   [Full Text] [Related]  

  • 17. [Increasing the effect of pyrogenic substances by simultaneous intravenous and intradermal administration].
    PIORKOWSKI G
    Med Klin; 1950 May; 45(20):630-1. PubMed ID: 15438529
    [No Abstract]   [Full Text] [Related]  

  • 18. Interleukin (IL)-6 and IL-1 beta act synergistically within the brain to induce sickness behavior and fever in rats.
    Harden LM; du Plessis I; Poole S; Laburn HP
    Brain Behav Immun; 2008 Aug; 22(6):838-49. PubMed ID: 18255258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Could the WHO model list of essential medicines do more for the safe and appropriate use of injections?
    Logez SM; Hutin YJ; Holloway K; Gray R; Hogerzeil HV
    J Clin Pharmacol; 2004 Oct; 44(10):1106-13. PubMed ID: 15342611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the bacterial pyrogenic substances.
    HATTA S; AOYAMA K; TANJI S
    Jpn Med J (Natl Inst Health Jpn); 1950 Apr; 3(2):125-35. PubMed ID: 14794291
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.